TABLE 3.
Hazard ratio for death and cardiovascular events based on the Cr/CysC ratio in 1,966 adults with chronic kidney disease.
Crude |
Model 1 |
Model 2 |
||||
Hazard ratio (95% CI) | P | Hazard ratio (95% CI) | P | Hazard ratio (95% CI) | P | |
Composite outcomes | ||||||
Continuous (per 1 unit Cr/CysC) | 0.93 (0.87–0.99) | 0.02 | 0.87 (0.80–0.95) | 0.01 | 0.92 (0.85–0.99) | 0.05 |
Categorical | ||||||
Q1 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |||
Q2 | 0.67 (0.48–0.92) | 0.01 | 0.75 (0.53–1.01) | 0.08 | 0.82 (0.59–1.14) | 0.2 |
Q3 | 0.53 (0.38–0.74) | <0.001 | 0.62 (0.44–0.87) | 0.01 | 0.71 (0.50–1.01) | 0.06 |
Q4 | 0.39 (0.27–0.53) | <0.001 | 0.55 (0.37–0.82) | 0.01 | 0.69 (0.45–0.99) | 0.05 |
All-cause death | ||||||
Continuous (per 1 unit Cr/CysC) | 0.94 (0.86–1.02) | 0.1 | 0.83 (0.74–0.93) | 0.01 | 0.87 (0.78–0.97) | 0.02 |
Categorical | ||||||
Q1 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |||
Q2 | 0.68 (0.42–1.02) | 0.06 | 0.66 (0.42–1.04) | 0.08 | 0.78 (0.49–1.23) | 0.3 |
Q3 | 0.58 (0.37–0.91) | 0.02 | 0.57 (0.35–0.91) | 0.02 | 0.68 (0.42–1.10) | 0.1 |
Q4 | 0.39 (0.23–0.66) | <0.001 | 0.42 (0.24–0.74) | 0.01 | 0.54 (0.30–0.97) | 0.04 |
Cardiovascular events | ||||||
Continuous (per 1 unit Cr/CysC) | 0.92 (0.85–1.00) | 0.05 | 0.89 (0.80–0.99) | 0.04 | 0.93 (0.84–1.04) | 0.2 |
Categorical | ||||||
Q1 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |||
Q2 | 0.67 (0.45–0.99) | 0.05 | 0.79 (0.52–1.19) | 0.3 | 0.80 (0.53–1.21) | 0.3 |
Q3 | 0.53 (0.35–0.81) | 0.01 | 0.67 (0.43–1.03) | 0.07 | 0.72 (0.46–1.12) | 0.1 |
Q4 | 0.38 (0.24–0.61) | <0.001 | 0.60 (0.36–1.00) | 0.05 | 0.72 (0.43–1.21) | 0.2 |
Model 1, adjusted for age, sex, estimated glomerular filtration rate, and natural log of albuminuria. Model 2, additionally adjusted for diabetes, cardiovascular disease, body mass index, systolic blood pressure, current smoking, albumin, and the natural log of C-reactive protein. CI, confidence interval.